Unknown

Dataset Information

Association of plasma VEGF levels and the antidepressant effects of ketamine in patients with depression.


ABSTRACT:

Aims

Growing evidence suggests that vascular endothelial growth factor (VEGF) may be involved in the neuronal mechanisms underlying both depression aetiology and the response to ketamine treatments. The aim of this study was to examine whether changes in plasma VEGF levels are associated with the antidepressant effects of repeated ketamine infusions in patients with depression.

Methods

Ninety-six patients with depression were enrolled and received six ketamine infusions during a 12-day period. Depressive symptom severity and plasma VEGF levels were measured by the Montgomery-Åsberg Depression Rating Scale (MADRS) and an enzyme-linked immunosorbent assay (ELISA) respectively, at baseline, 13 days and 26 days.

Results

Despite a significant improvement in MADRS scores af

SUBMITTER: Zheng W 

PROVIDER: S-EPMC8132091 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature